Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Clinical Genetics Branch Eligibility Screening Survey

View source ↗

Summary

National Cancer Institute conducts an eligibility screening survey for a clinical trial spanning multiple cancer predisposition conditions, including Melanoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma, Li-Fraumeni Syndrome | Status: NOT_YET_RECRUITING